Enhanced photodynamic therapy of curcumin using biodegradable PLGA coated mesoporous silica nanoparticles
European Journal of Pharmaceutics and Biopharmaceutics · 2024
DOI: 10.1016/j.ejpb.2024.114503 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024. Verfasst von Muhammad Umair Amin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch-Str. 4, Marburg, Germany. Electronic address: umairami@staff.uni…. Hauptthemen laut MEDLINE: Silicon Dioxide, Photochemotherapy, Nanoparticles, Polylactic Acid-Polyglycolic Acid Copolymer. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Since the available treatments are not highly effective to combat cancer, therefore, the alternative strategies are unavoidable. Photodynamic therapy (PDT) is one of the emerging approaches which is target specific and minimally invasive. This study explores the successful development of Poly (D,L-lactide-co-glycolide) (PLGA) coated mesoporous silica nanoparticles (MSNs) and their augmented effects achieved by integrating curcumin (Cur) and cetyltrimethylammonium bromide (CTAB) in the polymeric layer and silica's pores, respectively. The synthesized nanocarriers (Cur-PLGA-cMSNs) have shown preferential targeting to the cellular organelles facilitated by CTAB's and Cur's affinity to mitochondria. CTAB and Cur-based PDT induced oxidative stress and generation of reactive oxygen species (ROS), resulting in dysfunctional mitochondria and triggered apoptotic pathways. PLGA coating has produced multifunctional effects, including; gatekeeping effects at pore openings, providing an extra loading site, enhancing the hemocompatibility of MSNs, and masking the free cur-related prolonged coagulation time. Cur-PLGA-cMSNs, as a multifaceted and combative approach with synergistic effects demonstrate promising potential to enhance outcomes in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch-Str. 4, Marburg, Germany. Electronic address: umairami@staff.uni-marburg.de.
- Department of Chemistry, Ångstr¨ om Laboratory, Uppsala University, 75237 Uppsala, Sweden.
- Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch-Str. 4, Marburg, Germany.
- Institute of General Pharmacology and Toxicology, Goethe University Frankfurt am Main, Germany.
Zitieren
APA
Umair Amin, M., Ali, S., Engelhardt, K. H., Nasrullah, U., Preis, E., Schaefer, J., Pfeilschifter, J., & Bakowsky, U. (2024). Enhanced photodynamic therapy of curcumin using biodegradable PLGA coated mesoporous silica nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2024.114503
Vancouver
Umair Amin M, Ali S, Engelhardt KH, Nasrullah U, Preis E, Schaefer J, et al. Enhanced photodynamic therapy of curcumin using biodegradable PLGA coated mesoporous silica nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 2024. doi:10.1016/j.ejpb.2024.114503
BibTeX
@article{UmairAmin2024,
author = {Umair Amin, Muhammad and Ali, Sajid and Engelhardt, Konrad H and Nasrullah, Usman and Preis, Eduard and Schaefer, Jens and Pfeilschifter, Josef and Bakowsky, Udo},
title = {Enhanced photodynamic therapy of curcumin using biodegradable PLGA coated mesoporous silica nanoparticles},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2024},
doi = {10.1016/j.ejpb.2024.114503}
}
EUVIMED